Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

Engagement and Clinical Impact of the Teleo Virtual Therapy Platform

The research study will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the pilot trial will examine examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Study Overview

• Status: Completed
• Conditions: Mood Disorders; Anxiety Disorders
• Intervention / Treatment: Other: Teleo; Other: Standard videoconferencing

Detailed Description

The research study will examine engagement in telehealth for children undergoing psychotherapy. The study in Phase I entails a pilot randomized trial with a goal to enroll 42 families, examining patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Engagement will be assessed using well-established measures - PRIME-O (modified) video coding (session 1), MTT-Y/MTTCG (sessions 1, 4) and attendance data (sessions 1-4). Clinicians in the study will deliver therapy to clients for 4 sessions, providing opportunity to measure temporal sustainment of any engagement differences.

• Study Type: Interventional
• Enrollment (Actual): 41
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • California
    • Stanford, California, United States, 94305
      • Stanford University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Receiving psychotherapy with a licensed professional on the Teleo platform
• Likely have at least 12 sessions remaining.
• Diagnosis of a mental health condition by a licensed clinician

Exclusion Criteria:

• Not under treatment with provider using Teleo platform

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Teleo; Participants in this group will under therapy for 4 sessions using the Teleo virtual therapy video platform, sessions will be recorded and questionnaires and clinical data will be measured.	Other: Teleo; Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.
Active Comparator: Standard videoconferencing; Participants in this group will under therapy for 4 sessions using standard video platforms (e.g. zoom or other publicly available product), sessions will be recorded and questionnaires and clinical data will be measured.	Other: Standard videoconferencing; Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
PRIME-O Video Coding Score	Assess therapeutic engagement using modified PRIME-O total score, group scores, and individual item sub-scores. Scores range from 0-40, higher scores indicate 'better' outcome.	Weeks 1, 2, 3, 4

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Attendance during Psychotherapy Sessions	Instances and frequency of appointment cancellations, appointment no-shows, and/or discontinuation of therapy will be recorded and analyzed.	One month
My Thoughts about Therapy - Caregiver (MTT-CG) engagement questionnaire scores	Caregivers will complete modified MTT-CG questionnaire to measure engagement across dimensions of the REACH client engagement framework - Relationship, Expectancy, Attendance, Clarity, and Homework. Scores range from 0-105, higher scores indicate 'better' outcome.	Post-intervention (at one month)
My Thoughts about Therapy - Youth (MTT-Y) engagement questionnaire scores	Youth will complete questionnaires to measure self-reported engagement across dimensions of the REACH client engagement framework - Relationship, Expectancy, Attendance, Clarity, and Homework. Scores range from 0-105, higher scores indicate 'better' outcome.	Post-intervention (at one month)

Collaborators and Investigators

• Sponsor: Stanford University
• Collaborators: National Institute of Mental Health (NIMH); MainSquare Co. (dba 'Teleo')
• Investigators: Principal Investigator: David S Hong, MD, Stanford University

Study record dates

Study Major Dates

• Study Start (Actual): July 1, 2024
• Primary Completion (Actual): August 15, 2025
• Study Completion (Actual): September 15, 2025

Study Registration Dates

• First Submitted: April 8, 2024
• First Submitted That Met QC Criteria: April 8, 2024
• First Posted (Actual): April 15, 2024

Study Record Updates

• Last Update Posted (Estimated): September 23, 2025
• Last Update Submitted That Met QC Criteria: September 17, 2025
• Last Verified: September 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Anxiety Disorders; Mood Disorders
• Other Study ID Numbers: 73203; R42MH136878 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No